Literature DB >> 20209309

Correlation between inflammatory mediators in the nasopharyngeal secretion and in the serum of children with lower respiratory tract infection caused by respiratory syncytial virus and disease severity.

Renata Amato Vieira1, Edna Maria de Albuquerque Diniz, Maria Esther Jurfest Rivero Ceccon.   

Abstract

OBJECTIVE: To determine whether the concentrations of inflammatory mediators (CCL5, soluble intercellular adhesion molecule type 1 [sICAM-1], TNF-alpha, IL-6 and IL-10) in the nasopharyngeal secretion and in the serum of children with lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) correlate with the clinical markers of disease severity.
METHODS: Between July of 2004 and December of 2005, 30 children less than three months of age, diagnosed with LRTI caused by RSV and admitted to a neonatal ICU, were included in this study.
RESULTS: The severity of disease at hospital admission, as determined with a modified clinical scoring system, presented a significant positive correlation with sICAM-1 and IL-10 concentrations in the nasopharyngeal secretion, as well as with IL-6 concentrations in the serum, of the patients. In addition, serum IL-6 concentrations presented a significant positive correlation with the duration of oxygen therapy and with the length of hospital stay.
CONCLUSIONS: At hospital admission, the concentrations of sICAM-1 and IL-10 in the nasopharyngeal secretion, as well as the concentration of IL-6 in the serum, could be used as markers of severity in patients with LRTI caused by RSV. The serum levels of IL-6 determined at admission could also be used to predict prolonged oxygen supplementation and hospital stay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209309     DOI: 10.1590/s1806-37132010000100011

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  19 in total

1.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

2.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

Review 3.  Systematic review of instruments aimed at evaluating the severity of bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  Paediatr Respir Rev       Date:  2017-02-15       Impact factor: 2.726

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

5.  Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.

Authors:  Anne Schaap-Nutt; Rachael Liesman; Emmalene J Bartlett; Margaret A Scull; Peter L Collins; Raymond J Pickles; Alexander C Schmidt
Journal:  Virology       Date:  2012-09-07       Impact factor: 3.616

Review 6.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

7.  Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.

Authors:  Annemieke Schuurhof; Riny Janssen; Hanneke de Groot; Hennie M Hodemaekers; Arja de Klerk; Jan Ll Kimpen; Louis Bont
Journal:  Respir Res       Date:  2011-09-12

8.  Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).

Authors:  Emma K Larkin; Tebeb Gebretsadik; Martin L Moore; Larry J Anderson; William D Dupont; James D Chappell; Patricia A Minton; R Stokes Peebles; Paul E Moore; Robert S Valet; Donald H Arnold; Christian Rosas-Salazar; Suman R Das; Fernando P Polack; Tina V Hartert
Journal:  BMC Pulm Med       Date:  2015-04-30       Impact factor: 3.317

9.  Human respiratory syncytial virus memphis 37 causes acute respiratory disease in perinatal lamb lung.

Authors:  Rachel J Derscheid; Albert van Geelen; Jack M Gallup; Thomas Kienzle; Daniel A Shelly; Tomas Cihlar; Robert R King; Mark R Ackermann
Journal:  Biores Open Access       Date:  2014-04-01

10.  Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells.

Authors:  Rachel J Derscheid; Albert van Geelen; Jodi L McGill; Jack M Gallup; Tomas Cihlar; Randy E Sacco; Mark R Ackermann
Journal:  Viruses       Date:  2013-11-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.